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Despite their crucial role in promoting virulence, relatively few T3SEs have well-11 characterized enzymatic activities or host targets. This is in part due to functional 12 redundancy within pathogen T3SE repertoires as well as promiscuous individual T3SEs 13 that can have multiple host targets. To overcome these challenges, we conducted 14 heterologous genetic screens in yeast, a non-host organism, to identify T3SEs that 15 target conserved eukaryotic processes. We screened 75 T3SEs from the plant 16 pathogen Pseudomonas syringae and identified 16 that inhibited yeast growth on rich 17 media and eight that inhibited growth on stress-inducing media, including the 18 acetyltransferase HopZ1a. We focused our further analysis on HopZ1a, which interacts 19 with plant tubulin and alters microtubule networks. We first performed a Pathogenic 20 Genetic Array (PGA) screen of HopZ1a against ~4400 yeast carrying non-essential 21 mutations and found 95 and 10 deletion mutants which reduced or enhanced HopZ1a 22 toxicity, respectively. To uncover putative HopZ1a host targets, we interrogated both the 23 INTRODUCTION 2 Bacterial pathogens of both plants and animals subvert key host processes in order to 3 suppress host immunity and manipulate nutrient supplies. Many Gram-negative 4 bacterial pathogens achieve this goal by delivering type III secreted effectors (T3SEs) 5 into the host cytosol where they manipulate the host in a variety of ways, including 6 modulating signaling pathways, transcription, intracellular transport, cytoskeletal stability, 7 and host defenses (Büttner and Bonas 2003; Jin et al. 2003; Cornelis 2006; Zhou and 8 Chai 2008; Lewis et al. 2009 ). Although many bacterial T3SEs have been shown to 9 generally suppress host immunity, we know relatively little about the specific virulence 10 targets and mechanisms of action of most T3SEs. This difficulty in functional 11 characterization of T3SE virulence mechanisms is due to a number of factors, including: 12 (1) redundant targeting of a given host protein by multiple effectors which confounds 13 analysis of individual T3SE deletion mutants; (2) promiscuous individual effectors which 14 can target multiple host proteins, thereby making it difficult to ascribe a virulence 15 function to any individual target (Lewis et al. 2011; Deslandes and Rivas 2012) ; (3) 16 effectors often show no similarity to proteins or domains with characterized functions, 17 limiting bioinformatic approaches to infer effector functions; and (4) effectors can trigger 18 immune responses as a result of host recognition, which complicates virulence target 19 identification. 20 21 In order to gain new insights into the biochemical functions and host targets of bacterial 22 T3SEs, a number of research groups have utilized the model organism Saccharomyces 23 cerevisiae (yeast) as a tool (Yoon et al. 2003; Alto et al. 2006; Kramer et al. 2007 ; 24 1 2010). The rationale for using yeast to characterize bacterial effectors rests on the fact 2 that many biological processes (for example central metabolism, the control of 3 cytoskeleton dynamics, vesicle trafficking, signal transduction, DNA metabolism and cell 4 cycle processes) are conserved amongst eukaryotes (Siggers and Lesser 2008; Curak 5 et al. 2009; Botstein and Fink 2011; Dolinski and Botstein 2007) . Therefore, effectors 6 that target a conserved cellular process in a higher eukaryote may also act on the same 7 cellular process in the simpler and genetically-tractable yeast system. This is particularly 8 attractive if the original host is not readily amenable to high-throughput assays. Another 9 advantage of studying bacterial T3SEs in the yeast system is that the expression of 10 non-effector bacterial proteins does not generally affect yeast growth (Slagowski et al. 11 2008). This indicates that most fitness defects observed upon T3SE expression in yeast 12 is specifically due to the T3SE, and not simply due to the heterologous overexpression 13 of bacterial proteins. Finally, the expression of translocated effector proteins from both 14 plant and animal pathogens has been shown to inhibit yeast growth by targeting 15 conserved eukaryotic proteins (Munkvold et al. 2008; Siggers and Lesser 2008; Curak 16 et al. 2009; Salomon et al. 2011) . For instance, the Yersinia T3SE YopJ has been 17 shown to disrupt mammalian innate immunity by preventing the activation of MAPK 18 kinase (MAPKK) and subsequently blocking the MAPK and NFκB signaling pathways 19 (Orth et al. 1999; Orth et al. 2000) . Even though yeast cells lack key components of the 20 mammalian innate immune system, YopJ was shown to inhibit MAPK pathways in yeast 21 by preventing the activation of MAPKK as previously observed in mammalian systems 22 (Yoon et al. 2003) . Similar to SGA, PGA queries a pathogen effector against a collection of viable yeast 21 deletion strains in a high-throughput array format to analyze effector functions. PGA 22 identifies those yeast deletion mutants that can either reduce or enhance effector-23 mediated growth defects, and subsequently guides the inference of functional 1 relationships between these yeast genes and the pathogen T3SEs (Alto et al. 2006; 2 Kramer et al. 2007 ). This PGA strategy was first used to identify yeast deletion mutants 3 that suppress Shigella T3SE IpgB2-induced toxicity (Alto et al. 2006 In this study, we hypothesized that T3SEs that target evolutionarily conserved plant 11 processes can regulate the same processes in yeast. Furthermore, if this conserved 12 process is important for optimal yeast growth, then the overexpression of T3SEs should 13 decrease yeast fitness. We expressed 73 P. syringae T3SEs in yeast and identified 24 14 effectors that reduced yeast fitness, including HopZ1a PsyA2. In addition, PGA analysis 15 identified yeast genes involved in genetic interactions with HopZ1a; this genetic 16 interaction profile was compared with previously generated SGA datasets to identify 17 yeast genes with interaction profiles similar (or congruent) to that of HopZ1a. In theory, 18 genetic interactors will function in pathways parallel or compensatory to the pathway 19 targeted by HopZ1a. More specifically, yeast genes with genetic interaction profiles 20 congruent to that of HopZ1a may potentially represent direct targets of HopZ1a. Among Sopko et al. 2006 ). In brief, Y7092 (the SGA query strain) with integrated 23 1 mutant array marked with KAN R , which represents each single mutant colony four times 2 on the array. Y7092 carrying HOΔ::NAT R (SN851) was used as a negative control strain. 3 The MATa/α diploids were selected on YPD supplemented with clonNAT (100 μg/ml) 4 and G418 (200 μg/ml) at 30° for two days. Diploid cells were pinned onto enriched 5 sporulation media (20 g/L agar, 10 g/L potassium acetate, 1 g/L yeast extract, 0.5 g/L 6 glucose, 0.1 g/L amino acids-supplement) and allowed to sporulate at 22° for at least 7 one week. The spores were pinned onto synthetic dextrose media (SD) -His/Arg/Lys + 8 clonNAT/canavanine/thialysine and incubated at 30° for two days to select for MATa 9 haploid meiotic progeny. The drugs canavanine and thialysine were used at 50 μg/ml. 10 The MATa haploid meiotic progeny were subsequently pinned onto SD -His/Arg/Lys + 11 clonNAT/ canavanine/ thialysine/ G418 plates twice to select for the final MATa meiotic 12 progeny carrying both the kan R (yeast deletion strains) and NAT R (GAL1-T3SE-FLAG 13 constructs) markers. To induce for T3SE expression, the MATa haploid meiotic progeny 14 from final selection were pinned onto the synthetic galactose (SG) media -His/Arg/Lys 15 + clonNAT/canavanine/thialysine/G418, plates were incubated at 30° for two day. We 16 quantified colony sizes using an adapted SGA protocol (Baryshnikova et al. 2010a).
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Confirmation of PGA interactors: Yeast deletion strains that were either putative 19 suppressors or synthetic lethal interactors from the PGA screens were streaked out on 20 YPD with 200 μg/ml of G418 (Invitrogen Life Technologies, USA) and incubated at 30° 21 for 2 -3 days. Single colonies of each deletion strain were patched onto YPD plates in 22 1 -2 cm 2 patches and incubated at 30° for 1 overnight to allow for actively growing 23 yeast cultures. A single colony of wild type yeast from the deletion array border was 1 also streaked out and patched onto YPD plates as control strains. Each yeast deletion 2 strain was scraped off from the patches (~10 8 -10 9 cells) using sterile toothpicks and 3 arrayed into a 96-well microtiter plate containing 200 μl of sterile water. Yeast cells were 4 washed once with 200 μl of 0.1 M lithium acetate by centrifugation for 5 min at 1,500 x g 5 at 20° in a centrifuge with a microtiter plate rotor. Each well of pelleted yeast cells was 6 resuspended with 180 μl of transformation mix (120 μl of 50% w/v PEG-3350, 18 μl of 1 7 M lithium acetate, and 25 μl of boiled single-stranded carrier DNA). 60 μl each of 8 resuspended cells were subsequently transferred to 96-well microtiter plates containing 9 either 1 μl of purified plasmid DNA pBA350V (empty vector) or 1 μl of purified plasmid 10 DNA (pBA350V-hopZ1a and pBA350V-hopF2). The remaining 60 μl of cells served as a 11 mock transformation control. The 96-well microtiter plates were incubated at 30° for 30 12 min followed by heat shock at 42° for 30 min. Cells were harvested by centrifugation for 13 10 min at 1,500 x g at 20° and resuspended in 100 μl of SD. 50 μl of transformed or 14 mock-transformed cells were plated on SD-Leu and incubated at 30° for 3 days. 15 Transformants carrying either pBA350V or pBA350V-T3SE (pBA350V-hopZ1a and 16 pBA350V-hopF2) were grown on SD-Leu plates and were subsequently used for 17 confirmation by spot dilution assays. For spot dilution assays to confirm the putative PGA hits as either suppressors or 4 synthetic lethal interactors, the deletion strains carrying either the empty vector 5 (pBA350V) or the effector of interest (pBA350V-hopZ1a) were grown in synthetic drop-6 out media lacking Leu with 2% raffinose (SR-Leu) for two overnights at 30° and 200 7 RPM. The overnight cultures were serially diluted 15-fold and spotted onto SD-Leu, SG-8 Leu, SD-Leu and 0.5 M NaCl, or SG-Leu and 0.5 M NaCl. Spot dilutions were grown for 9 two to three days before being photographed. Spot assays were quantified using an 10 unbiased visual toxicity score (between 1 to 5), where 1 represented the strongest 11 toxicity (1 spot grew) and 5 represented the least toxicity (all 5 spots grew). A fitness 12 defect score was subsequently calculated using the toxicity score to compare the The dynamic exclusion was applied using an exclusion duration of 145s. 19 We performed a fitness-based screen of P. syringae T3SEs in yeast to gain insights into 20 the molecular functions of phytopathogenic T3SEs. We screened T3SEs from three 21 widely studied P. syringae strains: 22 T3SEs from P. syringae pv. tomato DC3000 22 (PtoDC3000); 12 T3SEs from P. syringae pv. syringae B728a (PsyB728a); and 17 23 16 T3SEs from P. syringae pv. phaseolicola 1448A (Pph1448a). These three strains have 1 finished genome sequences and represent three of the five major P. syringae 2 phylogroups (phylogroups 1, 2, and 3, respectively) (Hwang et al. 2005) . We also 3 screened 12 T3SEs from P. syringae pv. maculicola ES4326 (PmaES4326), which 4 belongs to phylogroup 4. Finally, we screened three additional T3SEs from the HopZ In order to examine the phenotypic consequence of T3SE expression in yeast, we used 17 serial dilution spot assays on rich media with glucose (T3SE-repressing) and with 18 galactose (T3SE-inducing) media to identify those P. syringae effectors that inhibit yeast 19 growth. As expected, we did not observe fitness defects on T3SE-repressing media 20 ( Figure S2 Figure S3C) . By comparing the colony size of each deletion mutant on glucose (T3SE-7 repressing) or galactose (T3SE-inducing) media, we classified those deletion mutants 8 with increased or decreased colony size compared to a control array as either 9 suppressors or negative genetic interactors of HopZ1a activity, respectively. The control 10 array was constructed by crossing the same array of ~4400 deletion mutants with a 11 query strain carrying only the NAT R drug resistance cassette at the HO locus (no 12 integrated T3SE). This allowed identification of yeast deletion mutants that were 13 sensitive to galactose and/or NaCl even in the absence of HopZ1a expression. In Given that wild type HopZ1a only inhibited yeast growth at high osmolarity (1 M NaCl), 21 we assessed the fitness of ~4400 deletion mutants carrying GAL-hopZ1a on media 22 containing galactose and various concentrations of NaCl. At 0.25 M and 0.5 M NaCl, we 23 initially identified 137 deletion mutants with reduced HopZ1a toxicity (suppressors) and 1 53 deletion mutants with enhanced HopZ1a toxicity (negative genetic interactors; data 2 not shown). To confirm the phenotypes of these 190 deletion mutants, we conducted a 3 secondary screen by transforming the same haploid yeast deletion strains with a single 4 copy plasmid (pBA350V) carrying GAL-hopZ1a, and then used spot dilution assays to We did not identify significant enrichment of GO processes in the HopZ1a negative 1 genetic interactors. However, two negative genetic interactors of HopZ1a, YKE2 and 2 BER1, are involved in regulating tubulin folding and microtubule-related processes 3 (Figure 2A) . Additionally, we identified both suppressors (BEM2, BEM3 and RRD1) and 4 negative genetic interactors (SLA1) that are involved in regulating the actin cytoskeleton 5 (Figure 2A and B) . Actin and microtubule cytoskeletons are both involved in 6 fundamental processes such as cell division and intracellular trafficking, raising the 7 intriguing possibility that our genetic interaction screen identified genes whose functions 8 influence both of these two important cytoskeletal components. 9 10 Predicting HopZ1a targets by congruence analysis of genetic interactors 11 Analysis of the HopZ1a genetic interactors revealed several biological processes that 12 may be disrupted by HopZ1a, yet this information provided limited insight regarding its 13 direct targets. We therefore sought to predict direct targets by identifying yeast gene 14 disruptions that show similar (i.e. congruent) genetic interaction profiles to HopZ1a. This 15 approach is similar to one used previously to identify drug targets in yeast (Costanzo et 16 al. 2010 ) and assumes that if HopZ1a activity disrupts a given target protein's function 17 in yeast, the HopZ1a PGA profile would be similar (or 'congruent') to the SGA profile of 18 the corresponding gene knockout strain lacking this putative target ( Figure 3A and B) . 19 We focused our congruency analyses on negative genetic interactors since previous 20 work has indicated that these interactions are easier to interpret than suppressors (Ye (Table S1 ). We identified 99 yeast 6 genes with congruence scores ≥ 2, indicating similarity to the negative genetic 7 interaction profile of HopZ1a ( Figure 3C and Table S1 ). This set of yeast genes with 8 congruent interaction profiles was significantly enriched for genes involved in replication 9 fork processing (p<0.0001) and for genes involved in microtubule-based processes 10 (p<0.0004) ( Figure 3C ). We were particularly interested in this second group of genes, 11 which includes several microtubule-directed motor proteins such as kinesins (i.e. CIN8, 12 KIP2, VIK1, and KAR3) and proteins in the dynein-dynactin complex (i.e. NIP100 and 13 DYN1) ( Figure 3C ).
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P. syringae T3SEs Compromise Yeast Fitness
15
Bridging genetic and physical interaction data 16 Given that the natural arena for HopZ1a activity is within plant cells, we examined our 17 set of yeast genes showing genetic interactions with HopZ1a for functional overlap with 18 datasets from two previous studies that had identified direct physical interactions 19 between A. thaliana genes and P. syringae T3SEs by using yeast two-hybrid screens 20 (Mukhtar et al. 2011; Lewis et al. 2012) . Of note, Arabidopsis kinesins were identified as 21 HopZ-interacting proteins in both of these previous studies. This overlap between the 22 genetic and physical interactions observed for HopZ1a motivated further investigation 1 into whether Arabidopsis kinesins represent direct targets of HopZ1a activity. In this study, we took advantage of the genetic tractability of yeast to identify putative 2 targets of the T3SE HopZ1a from the plant pathogen P. syringae. By integrating and 3 expressing 73 P. syringae T3SEs in yeast, we identified 24 effectors that altered yeast 4 fitness on rich media or under high osmolarity conditions, including HopZ1a. We then 5 used a high-throughput PGA screen and analysis of physical interaction datasets to 6 identify kinesin targets of the T3SE, HopZ1a. ). We tested 20 of these same 27 PtoDC3000 effectors and observed fitness 12 phenotypes consistent with these previous data in all cases except for HopAO1, HopD1 13 and HopN1 (Munkvold et al. 2008; Munkvold et al. 2009 ). While we integrated T3SEs 14 into the yeast genome and expressed them as single copy genes, Munkvold et al. 15 expressed T3SEs on a high-copy plasmid. Differences in gene dosage may thus be 16 contributing to the three instances where our data diverge from this previous report.
17 18 Our initial screen provides numerous interesting leads for further study. Notably, P. The PGA approach can be used to infer the function of T3SEs by identifying those yeast 12 genes whose deletions either suppress or enhance T3SE lethality. Intuitively, deletion 13 strains that suppress T3SE lethality (known as suppressors) can reveal genes involved 14 in the same pathways as putative T3SE targets. This can be particularly informative 15 when the T3SE activates a pathway resulting in toxicity, as was observed with the 16 Shigella T3SE IpgB2 which activates the Rho1p GTPase signaling pathway in yeast 17 (Alto et al. 2006 ). However, one caveat of the suppressor screen is that we may identify 18 mutants that suppress T3SE lethality by a general mechanism (i.e. by induction of a 19 general stress response); such genes are unlikely to be informative for the inference of 20 T3SE function. 21 22 Deletion mutants that exacerbate the fitness cost of T3SE activity can be explained by 1 either of two alternate mechanisms resulting in 'negative genetic interactions'. In one 2 case, the T3SE acts in the same pathway as the 'negative genetic interactor', resulting 3 in cumulative insults to an essential pathway or complex (Boone et al. 2007; Dixon et al. 4 2009). Alternatively, the T3SE and 'negative genetic interactor' may act on parallel 5 pathways, which redundantly contribute to an essential function ( Figure 3A) Applying these principles, we identified SGA profiles that were most similar to the 19 HopZ1a PGA profile and analyzed them for functional enrichment. Genes involved in 20 replication fork processing (p < 0.0001) and microtubule-based processes (p < 0.0004) 21 were enriched in the subset with HopZ1a-congruent interaction profiles. We were 22 particularly interested in microtubule-associated processes since HopZ1a can disrupt 23 microtubules in plants and interacts with tubulin in both plant and animal cells (Lee et al. 1 2012). Indeed, kinesins (known microtubule-guided motor proteins) were identified not 2 only through our congruency analysis, but also by two independent yeast-two hybrid 3 screens for Arabidopsis proteins that bind to related HopZ family members. The fact 4 that kinesins are found at the intersection of these three independent datasets indicates 5 that members of this family may indeed represent bona fide, direct targets of HopZ1a. In 6 support of this possibility, HopZ1a can acetylate both of the Arabidopsis kinesins 7 HINKEL and MKRP1 (Figure 4 ). Although HopZ1a has not been detected in mitochondria, we cannot rule out the 20 possibility that the mitochondrial kinesins identified by yeast two-hybrid assays are also 21 targeted by HopZ1a, especially considering that they are targeted by the P. syringae 22 T3SE HopG1 and are involved in plant immunity (Shimono et al. 2016 ). HopZ1a 23 acetylates MKRP1 at two distinct sites: T425 is just 'downstream' of the kinesin motor 1 domain while T820 is near its C-terminus ( Figure 4B ). In Nicotiana, the HINKEL ortholog 2 NACK1 is phosphorylated near the C-terminus at residues T675, T690 and T836 by Additional acetylation sites may exist on HINKEL and MKRP1 (and HopZ1a) since LC-10 MS/MS analysis is unable to detect all peptides generated from trypsin digests of the 11 proteins of interest; we only acquired 47-51% coverage of HINKEL, 56-63% coverage of 12 MKRP1, and 43-55% coverage of HopZ1a (Figure 4) . Thus, our acetylation analysis is 13 conservative and it remains possible that HopZ1a acetylates additional residues of 14 HINKEL and/or MKRP1 that we were unable to observe. Although HINKEL is acetylated 15 within its kinesin motor domain at positions S88 and T90, the corresponding residues 16 were not acetylated in MKRP1. The acetylation sites of MKRP1 are not present in 17 HINKEL (not shown) and HINKEL has a C-terminal DUF3490 domain that is absent 18 from MKRP1 (Figure 4) . Thus, if acetylation of these two kinesins is an important 19 function of HopZ1a in planta, they are likely to be regulated by contrasting mechanisms. We had hoped to demonstrate functional importance for HopZ1a acetylation of kinesins 1 by comparing the growth of P. syringae in transgenic Arabidopsis plants that 2 conditionally-overexpress either wild type HINKEL or putative acetyl-mimetic alleles 3 (with glutamine substitutions at S88 and T90). However, despite independent cloning 4 and transformation attempts by many of us (AHL, DPB, TL, and JZ), we were 5 consistently unable to detect even modest expression of HA-tagged recombinant 6 HINKEL in Agrobacterium-transformed Arabidopsis (data not shown). Although the 7 dexamethasone-inducible expression vector we employed (Aoyama and Chua 1997) 8 has been used successfully in the past by ourselves and by others, it is known that 9 leaky (uninduced) expression levels from the dexamethasone-dependent promoter are 
